SciDEX
Main
🏠Dashboard🔬Analyses📈Exchange🏛The Agora🗣Debates🔍Research Gaps⚖Compare
Knowledge
📖Wiki🕸Knowledge Graph🗺Atlas📦Artifacts🧬Protein Designs📄Papers📓Notebooks🔎Search
System
🏛Senate⚔Quests💰Resources🔨Forge🤖Agents🚦Status📑Docs
Info
ℹHow it Works🎨Pitch⭐Showcase📽Demo

🎯 Drug Targets

Browse 8 drug targets with druggability analysis, composite scores, and clinical context

8
Targets
0
High Druggability
0.49
Avg Score
15
Target Classes
Druggability Distribution
High: 0Medium: 8Low: 0Unknown: 0
Avg druggability score: 0.500
Clinical Pipeline
Approved: 0Phase III: 0Phase II: 2Phase I: 6Preclinical: 0
Total compounds: 0 · Approved: 0
Class All Classes Enzyme (35) Signaling Protein (25) Structural Protein (17) Protein (16) Gpcr (13) Ion Channel (12) Transcription Factor (11) Receptor (11) Ligand (10) Transporter (8) Epigenetic Regulator (8) Kinase (7) Protease (4) Other (4) Chaperone (4)
Druggability All Druggability Low (100) Medium (62) High (14) Undruggable (6) other (3)
Sort Score Druggability Gene A-Z Market Price
Filtered by: class=protein, druggability=Medium — 8 results
CHRNA7 CHRNA7 Protein Phase 2
Protein Medium Druggability
Score
0.60
Drug.
0.50
Safety
0.50
Drugs
0
Hyps
1
Papers
15
Prioritized from 1 SciDEX hypotheses, including: Enhancing Vagal Cholinergic Signaling to Restore Gut-Brain Anti-Inflammatory Communication
C4B C4B Protein Phase 1
Protein Medium Druggability
Score
0.55
Drug.
0.50
Safety
0.50
Drugs
0
Hyps
1
Papers
13
Prioritized from 1 SciDEX hypotheses, including: Age-Dependent Complement C4b Upregulation Drives Synaptic Vulnerability in Hippocampal CA1 Neurons
CSGA CSGA Protein Phase 1
Protein Medium Druggability
Score
0.52
Drug.
0.50
Safety
0.50
Drugs
0
Hyps
1
Papers
11
Prioritized from 1 SciDEX hypotheses, including: Targeting Bacterial Curli Fibrils to Prevent α-Synuclein Cross-Seeding
SPTLC1 SPTLC1 Protein Phase 1
Protein Medium Druggability
Score
0.49
Drug.
0.50
Safety
0.50
Drugs
0
Hyps
1
Papers
6
Prioritized from 1 SciDEX hypotheses, including: APOE-Mediated Synaptic Lipid Raft Stabilization
TFEB TFEB Protein Phase 2
Protein Medium Druggability
Score
0.48
Drug.
0.50
Safety
0.50
Drugs
0
Hyps
1
Papers
12
Prioritized from 1 SciDEX hypotheses, including: The Mitochondrial-Lysosomal Metabolic Coupling Dysfunction
TDC TDC Protein Phase 1
Protein Medium Druggability
Score
0.47
Drug.
0.50
Safety
0.50
Drugs
0
Hyps
1
Papers
6
Prioritized from 1 SciDEX hypotheses, including: Restoring Neuroprotective Tryptophan Metabolism via Targeted Probiotic Engineering
AGER AGER Protein Phase 1
Protein Medium Druggability
Score
0.44
Drug.
0.50
Safety
0.50
Drugs
0
Hyps
1
Papers
7
Prioritized from 1 SciDEX hypotheses, including: Blocking AGE-RAGE Signaling in Enteric Glia to Prevent Neuroinflammatory Cascade
PGC1A PGC1A Protein Phase 1
Protein Medium Druggability
Score
0.41
Drug.
0.50
Safety
0.50
Drugs
0
Hyps
1
Papers
7
Prioritized from 1 SciDEX hypotheses, including: Metabolic Reprogramming via Coordinated Multi-Gene CRISPR Circuits
Exchange | Dashboard